Acotiamide Hydrochloride Hydrate acts as an acetylcholinesterase inhibitor. It is pending approval in the United States; ten clinical trials have been successfully completed. It is a drug manufactured and approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. . Reference standards of Acotiamide Hydrochloride Hydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Acotiamide Hydrochloride Trihydrate
Catalogue No.:PA 28 78000
CAS :
Molecular Formula : C21H37ClN4O8S
Molecular Weight : 541
Ethyl 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxylate
Catalogue No.:PA 28 78510
Molecular Formula : C15H16N2O6S
Molecular Weight : 352.36
Ethyl 2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxylate acetate
Catalogue No.:PA 28 78520
Molecular Formula : C17H18N2O7S
Molecular Weight : 394.4
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
